Quick Takeaways
- Anthony Gregg Lapointe has 3 issuer positions tracked on this page.
- Estimated disclosed ownership value: $238,250.
- Recent insider filing activity is available below.
- Info
- Insider Ownership
Insider Trading & Ownership of Anthony Gregg Lapointe
- Location
- Gaithersburg, MD
- Summary
- The estimated net worth of Anthony Gregg Lapointe is at least $238,250 dollars as of 23 Jan 2026. Anthony Gregg Lapointe is the Director of RIGEL PHARMACEUTICALS INC and owns shares of RIGEL PHARMACEUTICALS INC (RIGL) stock worth about $238.2K.
- Signature
- /s/ Ben Harshbarger, as attorney-in-fact for Gregg Lapointe
- All Insider Reports
- All Insider Reports
Follow Filing Activity
Follow Anthony Gregg Lapointe and return when a new Insider Trading filing appears.
This tracks SEC filing changes for this page using existing product update flows.
What Changed
- Largest disclosed position: RIGEL PHARMACEUTICALS INC ($238,250).
- Past-year value change for that position: .
Why This Matters
- This page translates Forms 3/4/5 into a quick ownership context before you inspect each transaction row.
- You can cross-check role, issuer, and filing chronology directly against the SEC source.
Official SEC Source
Filed on Form 4
Insider ownership context is sourced from SEC Forms 3, 4, and 5.
See Original FilingOwnership of Anthony Gregg Lapointe
| Symbol | Company | Relationship | Holdings Value | Past Year Net Change | Change % | Report Period |
|---|---|---|---|---|---|---|
| RIGL | RIGEL PHARMACEUTICALS INC | Director | $238,250 | 23 May 2025 | ||
| ATXS | Astria Therapeutics, Inc. | Director | 23 Jan 2026 | |||
| SNGX | SOLIGENIX, INC. | Director | 20 Jun 2025 |
Insider Transactions Reported by Anthony Gregg Lapointe:
| Sym | Company | Class | Transaction | % | Value $ | * Price $ | Shares | Shares After | Date | Ownership |
|---|
* An asterisk sign (*) next to the price indicates that the price is likely invalid.